Supreme Court Reverses on Bt Eggplant Field Trials, Dismisses Case as Moot

The Supreme Court, in a significant reversal, has dismissed the consolidated petitions involving the field trials of Bacillus thuringiensis (Bt) eggplant, also known as Bt talong. In its Resolution dated July 26, 2016, the Court granted the motions for reconsideration and set aside its earlier December 8, 2015 Decision, which had permanently enjoined the field testing and declared the Department of Agriculture's Administrative Order No. 8, series of 2002 (DAO 08-2002) null and void. The reversal was based on the ground of mootness, a fundamental principle in judicial review.

The Case's Origin: The Bt Talong Field Trials

The case arose from field trials for a genetically modified eggplant designed to resist the fruit and shoot borer, a destructive pest. The trials were conducted from 2007 to 2010 by the University of the Philippines Los Baños (UPLB) and other petitioners, following the issuance of two-year Biosafety Permits by the Bureau of Plant Industry (BPI). These permits were issued after a biosafety risk assessment was completed under DAO 08-2002.

In 2012, respondents, including Greenpeace Southeast Asia and MASIPAG, filed a Petition for Writ of Kalikasan and Continuing Mandamus before the Supreme Court. They alleged that the field trials violated the constitutional right to health and a balanced ecology, citing the lack of an Environmental Compliance Certificate, failure to conduct public consultations, and the application of the precautionary principle due to scientific uncertainty over the safety of Bt talong.

The Initial Rulings and the 2015 Decision

The Court of Appeals (CA) ruled in favor of the respondents in 2013, ordering a permanent cease and desist on the field trials. The CA applied the precautionary principle, noting the potential for irreversible harm to the environment.

On review, the Supreme Court in its December 8, 2015 Decision affirmed the CA with modification. It held that the precautionary principle applied and that the case was not moot due to exceptions involving paramount public interest and the issue being capable of repetition yet evading review. The Court also declared DAO 08-2002 null and void for failing to comply with the National Biosafety Framework, and temporarily enjoined all GMO applications until a new administrative order was promulgated.

The Reversal: The Case Became Moot

The Court's 2016 Resolution reversed this course. It held that the case had become moot and academic because the Biosafety Permits had expired and the field trials were completed and terminated. As stated in the Resolution, an action is moot when it "no longer presents a justiciable controversy because the issues involved have become academic or dead."

The Court clarified that the completion of field trials does not automatically lead to commercialization. Under DAO 08-2002, there are three distinct stages before a GMO becomes commercially available, and subsequent stages require separate permits and clearances. Since the case never went beyond the field testing phase, there were no guaranteed after-effects that demanded adjudication.

The Court also rejected the application of the "capable of repetition yet evading review" exception, noting that the petition specifically targeted field testing under the now-superseded DAO 08-2002. A new regulatory framework, Joint Department Circular No. 1, series of 2016 (JDC 01-2016), had been issued by multiple government agencies, providing a substantially different and more comprehensive system for GMO regulation, including enhanced public participation and risk assessment guidelines.

The Mootness Doctrine and Its Exceptions

The Resolution reiterates the rule that courts only adjudicate actual, ongoing controversies, as required by Section 1, Article VIII of the 1987 Constitution. While jurisprudence recognizes four exceptions to the mootness principle—grave violation of the Constitution, exceptional character and paramount public interest, need to formulate controlling principles, and capability of repetition yet evading review—the Court found none of these applicable to the Bt talong case.

The Court emphasized that no perceivable benefit to the public could be gained by resolving the case on the merits, as the regulatory landscape had changed. Resolving the petition would be an "unnecessary scholarly exercise" and could hinder scientific advancement.

Practical Takeaways

• Mootness is a key defense. A case can be dismissed if the issues have been resolved by subsequent events, such as the expiration of permits or completion of the challenged activity.
• Exceptions are strictly applied. The Supreme Court will only use exceptions to the mootness doctrine when there is a clear and perceivable public benefit.
• Regulatory frameworks evolve. The reversal highlights that legal challenges to specific projects can be overtaken by changes in the law or implementing rules, as seen with the shift from DAO 08-2002 to JDC 01-2016.
• Distinct regulatory stages. For GMOs, each phase—contained use, field testing, propagation, and commercialization—requires separate permits and clearances, and completion of one stage does not guarantee approval for the next.
• The precautionary principle is not absolute. While a valid legal principle, its application depends on the specific facts and the existence of a live controversy.

This article is general information and not legal advice. For your specific situation, consult a lawyer or ask ASG Legal AI.